DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Bardia A, Tolaney SM, Loirat D. et al.
ASCENT: A randomized phase III study of sacituzumab govitecan (SG) vs. treatment of physicianʼs choice (TPC) in patients (pts) with previously treated metastatic triple-negative breast cancer (mTNBC).
Ann Oncol 2020;
31 (Suppl. 04) S1142-S1215
doi:10.1016/annonc/annonc325
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.